Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Sonoma Pharmaceuticals logo — Empathy lead, Science driven

Sonoma Pharmaceuticals

Empathy lead, Science driven

Founded 1999 United States Boulder, United States 24 employees Post-IPO Equity Total: $77.90M Health Care

General Information

Company Name Sonoma Pharmaceuticals
Founded Year 1999
Location United States Boulder, United States
Employees 24
Industries Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Sonoma Pharmaceuticals. To contact Sonoma Pharmaceuticals, visit sonomapharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sonoma Pharmaceuticals compare?

A PDF of Sonoma Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sonoma Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sonoma Pharmaceuticals

Sonoma Pharmaceuticals, with its slogan "Empathy lead, Science driven," is a global healthcare leader dedicated to developing and commercializing innovative wound care and dermatological solutions. Established in 1999 in the United States, the company offers safe early-intervention products that ensure fast relief without side effects or other limitations. It has over 20 years of experience in harnessing the patented Microcyn® Technology to create a diverse portfolio that caters to the needs of patients and healthcare professionals. Sonoma's mission is to improve patient outcomes by providing reliable, unique solutions that facilitate optimal conditions for wound care and skin health. The company collaborates with industry experts and community partners to bring groundbreaking products to the market, constantly pushing the boundaries of what's possible in healthcare. Its $1.70M Post-IPO Equity investment on 26 October 2023 underscores investor confidence in the company's potential to drive innovation and address unmet needs in the Health Care industry.

Business keywords: healthcare solutions, HOCl based products, wound care, dermatology, eye care, animal health, global leader, prescription products, non-prescription products, advanced wound management, women's health, unmet medical needs, lowering healthcare costs

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $1.70M -
26 Oct 2023
Post IPO Equity $70.00M 8
8VC Arch Venture Partners Lilly Asia Ventures
8VC, Arch Venture Partners +6
30 Sep 2020
Post IPO Equity $1.60M -
29 Nov 2019
Post IPO Equity $4.60M 1
Montreux Equity Partners
Montreux Equity Partners
06 Mar 2018

Sonoma Pharmaceuticals Alternatives & Competitors

View All Alternatives
Sonoma Pharmaceuticals vs
Chesson Laboratory Associates, Inc.
Chesson Laboratory Associates, Inc. United States

Providing innovative polymer-based medical solutions for healthcare professionals and consumers acro...

Debt Financing
5 employees
Biotechnology, Health Care
Sonoma Pharmaceuticals vs
Links Medical Products, Inc.
Links Medical Products, Inc. United States

Your Link to Innovative Caring Products

11 employees
Health Care, Manufacturing
Sonoma Pharmaceuticals vs
GestVision, Inc.
GestVision, Inc. United States

Filling the Gap in Maternal Health

Seed
3 employees
Health Care
View all alternatives

FAQ About Sonoma Pharmaceuticals

Empathy lead, Science driven
Sonoma Pharmaceuticals was founded in 1999.
Sonoma Pharmaceuticals is headquartered in Boulder, United States.
Sonoma Pharmaceuticals operates in Health Care. Its work centres on healthcare solutions, HOCl based products, wound care and dermatology.
Sonoma Pharmaceuticals has approximately 24 employees.
Sonoma Pharmaceuticals has completed 4 funding rounds, raising a total of $77.90M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Sonoma Pharmaceuticals include Chesson Laboratory Associates, Inc., Links Medical Products, Inc., GestVision, Inc., Evofem Biosciences, Bruin Biometrics, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sonoma Pharmaceuticals and Chesson Laboratory Associates, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sonoma Pharmaceuticals, https://bouncewatch.com/company/sonoma-pharmaceuticals, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout